Robert Hershberg
Algemeen Directeur bij HILLEVAX, INC.
Vermogen: 11 M $ op 31-05-2024
Actieve functies van Robert Hershberg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Directeur/Bestuurslid | 01-02-2013 | - |
Independent Dir/Board Member | 01-02-2013 | - | |
RECURSION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 20-03-2020 | - |
Independent Dir/Board Member | 20-03-2020 | - | |
HILLEVAX, INC. | Algemeen Directeur | 25-03-2020 | - |
Voorzitter | 25-03-2020 | - | |
Oprichter | 25-03-2020 | - | |
President | 25-03-2020 | - | |
UW Medicine | Corporate Officer/Principal | - | - |
Cajal Neuroscience, Inc.
Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery. | Directeur/Bestuurslid | - | - |
Loopbaan van Robert Hershberg
Eerdere bekende functies van Robert Hershberg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
FATE THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-05-2020 | 07-06-2024 |
Independent Dir/Board Member | 01-05-2020 | 07-06-2024 | |
NS WIND DOWN CO., INC. | Directeur/Bestuurslid | 02-03-2015 | 18-04-2022 |
Independent Dir/Board Member | 02-03-2015 | 18-04-2022 | |
CELGENE | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 | 01-01-2019 |
Corporate Officer/Principal | 01-07-2014 | 01-01-2016 | |
VentiRx Pharmaceuticals, Inc.
VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Directeur/Bestuurslid | 12-06-2006 | 01-03-2017 |
Algemeen Directeur | 01-09-2012 | 01-03-2017 | |
Hoofd Techniek/Wetenschap/O&O | 12-06-2006 | 01-03-2017 | |
Oprichter | 12-06-2006 | 01-03-2017 | |
President | 15-01-2010 | 01-03-2017 | |
░░░░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Robert Hershberg
The Salk Institute for Biological Studies | Doctorate Degree |
University of California, Los Angeles | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 16 |
2 |
Operationeel
Director/Board Member | 8 |
Independent Dir/Board Member | 5 |
Corporate Officer/Principal | 4 |
Sectoraal
Health Technology | 12 |
Consumer Services | 5 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
RECURSION PHARMACEUTICALS, INC. | Health Technology |
NS WIND DOWN CO., INC. | Health Technology |
FATE THERAPEUTICS, INC. | Health Technology |
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
VentiRx Pharmaceuticals, Inc.
VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Health Technology |
Silverback Therapeutics, Inc.
Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
Guide Therapeutics, Inc.
Guide Therapeutics, Inc. BiotechnologyHealth Technology Guide Therapeutics, Inc. develops biophotonic technology platform for the early detection of disease that leads to cancer. The company was founded by James Dahlman and Cory Sago and is headquartered in Tucker, GA. | Health Technology |
Cajal Neuroscience, Inc.
Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery. | Health Technology |
HilleVax, Inc. |
- Beurs
- Insiders
- Robert Hershberg
- Ervaring